Lawson Benjamin O, Khong Hung T
Honor Health Internal Medicine, Scottsdale Thompson Peak Medical Center, Scottsdale, AZ, U.S.A.
Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, U.S.A.
Anticancer Res. 2017 Mar;37(3):1365-1368. doi: 10.21873/anticanres.11456.
A 26-year-old male developed narcoleptic-like episodes while on pegylated interferon-alpha 2b (peg-IFN-α2b) therapy for stage IIIB melanoma. Once peg-IFN-α2b was discontinued, the narcoleptic-like episodes eradicated. A case report and review of the literature are presented in this article.
